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ABSTRACT
Chemically, methyl trans-cinnamate offers treatment at the three main reactive sites such as substitution at the phenyl 
ring, addition at the α,β-unsaturation, and substitution at the carboxylic methyl ester functionality. We focus our 
research to the amide and related derivatives of cinnamates because of their lesser known attributes towards antidiabetic 
activities. In this research, we modify methyl trans-cinnamate by amidating the carboxylic methyl ester functionality 
using several amines introduced in functional groups of methyl trans-cinnamate. A series of cinnamamide derivatives 
was synthesized and evaluated for α-glucosidase inhibitory effects. The structure of synthesized compounds was 
characterized by IR, melting point, UV, 1H NMR, 13C NMR, and mass spectral analysis. All 13 cinnamamide showed 
higher α-glucosidase activity than the starting compound. The substitution of cinnamic acid with an amide group 
altered the α-glucosidase inhibitory activity. Increased bulkiness and the chain length of the amine substituents 
decreased the inhibitory activity. Propylcinnamamide (3c) showed the most potent inhibitory activity among all the 
cinnamamide derivatives, all of which act through a competitive inhibitory mechanism. These compounds may be worth 
exploring further.
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ABSTRAK
Secara kimia, metil trans-sinamat menawarkan rawatan pada tiga tapak reaktif utama seperti penggantian pada gelang 
fenil, penambahan pada ketaktepuan α,β dan penggantian pada kefungsian karbosilik metil ester. Kami memfokuskan 
kajian ini kepada amida dan terbitan berkaitan sinamat kerana atribut yang kurang dikenali terhadap aktiviti 
antidiabetis. Dalam kajian ini kami mengubah suai metil trans-sinamat dengan keamidaan kefungsian karbosilik metil 
ester menggunakan beberapa amina yang diperkenalkan dalam kumpulan fungsian metil trans-sinamat. Beberapa 
terbitan sinamamida telah disintesis dan dinilai untuk kesan rencatan α-glucosidase. Struktur sintesis sebatian telah 
dicirikan oleh IR, titik lebur, UV, 1H NMR, 13C NMR dan analisis jisim spektrum. Kesemua 13 sinamamida menunjukkan 
aktiviti α-glucosidase yang tinggi berbanding sebatian pemula. Penggantian asid sinamik dengan kumpulan amida 
mengubah aktiviti perencatan α-glucosidase. Peningkatan berpukal dan panjang rantai bahan ganti amina 
mengurangkan aktiviti rencatan. Propilsinamamida (3c) menunjukkan aktiviti rencatan poten dalam kalangan terbitan 
sinamamida, dengan kesemuanya bertindak melalui mekanisme perencatan berpersaingan. Sebatian ini mungkin 
berbaloi untuk kajian lanjut.
Kata kunci: Perencat α-glucosidase; sintesis; terbitan sinamamida
INTRODUCTION
α-Glucosidase is a type of hydrolase enzyme that catalyzes 
the hydrolysis of terminal non-reducing carbohydrates into 
α-glucose (Park et al. 2013). Inhibition of α-glucosidase 
enzyme activity allows blood glucose levels to return 
within normal range (Bösenberg & van Zyl 2008). 
Glucosidase is responsible for the catalytic disruption of 
glycosidic bonds, which specifically depends on the 
amount of monosaccharides, the position of the cleavage 
site, and the configuration of the hydroxyl group in the 
substrate (Park et al. 2008a). Enzymatic hydrolysis of 
glycosidic bonds occurs through acid catalysis that requires 
two important residues such as proton donors and bases/
nucleophiles (Park et al. 2008b). α-Glucosidase inhibitors 
(IAGs), such as acarbose, nojirimycin, 1-deoxynojirimycin, 
miglitol, and voglibose, are widely used for the treatment 
of type 2 diabetes and obesity (Bösenberg & van Zyl 2008; 
Davies & Henrissat 1995; Liu et al. 2006; Mohammed et 
al. 2014; Van de Laar et al. 2008). They can also be used 
as a therapeutic target to treat viral infections, cancers, and 
hepatitis (Fischer et al. 1995; Mehta et al. 1998; Melo & 
Carvalho 2006).
Cinnamic acid derivatives have been reported to 
inhibit α-glucosidase (Babu et al. 2007; Huang et al. 2009; 
Narender et al. 2007; Phuwapraisirisan et al. 2008; Pili et 
al. 1995). The pharmacophore of cinnamic acid compound 
are phenyl ring, α,β-unsaturation and  carboxylic acid. It 
is known that cinnamic acid derivatives act as IAGs. Their 
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structure includes a substitution at para position within 
the aromatic functional group functionalized with an 
alkylester group (Matsuura et al. 2004). However, no 
cinnamamide derivatives have been tested for their 
α-glucosidase inhibitory ability. Therefore, we replaced 
the carboxylic acid moiety of cinnamic acid by an alkyl 
amine and predicted that it can have better inhibitory 
activity against α-glucosidase. In this study, we synthesized 
a series of cinnamamide derivatives and elucidated their 
structures with H-NMR, C-NMR, FTIR, ESI QToF MS, 
GCMS. We report their inhibitory effects against 
Saccharomyces cerevisiae and rat intestinal α-glucosidase.
MATERIALS AND METHODS
CHEMICAL AND INSTRUMENTS
All solvents were dried and distilled according to standard 
procedure. 1H were recorded on JEOL NMR ECZ500R using 
500 MHz instrument and 13C NMR spectra were recorded 
on JEOL NMR ECZ500R using 125 MHz instrument in 
deuterochloroform. Chemical shifts (δ) are reported in 
parts per million (ppm) downfield from tetramethylsilane 
(δ 0.00) or CHCl3 (δ 7.26) for 1H NMR and δ 77.0 for 13C 
NMR as an internal standard, and coupling constants are 
reported in Hertz. ESI QToF MS Mass Spectra were 
recorded on Waters Xevo® G2-XS QToF. IR spectra were 
obtained on Bruker Tensor II. Analytical thin layer 
chromatography (TLC) was performed on Merck silica gel 
plates (Art5715 Kiesel gel 60F254 0.25 mm) and preparative 
TLC was performed using Merck silica gel plates (Art5744 
Kiesel gel 60F254 0.5 mm). Silica gel column chromatography 
was carried out on Daisogel IR-60. Methyl trans-
cinnamates obtained from isolation of Alpinia malaccensis 
using hydrodistillation methode was chosen as the starting 
material, which was characterized by GCMS, LCMS, ESI-
QToF MS, 1H NMR, 13C NMR, and FTIR. 
EXPERIMENTS
Hydrolysis of methyl trans-cinnamate 
In a 250 mL round-bottomed flask, methyl trans-cinnamate 
(0.012 mol), 2M NaOH, and 95% ethanol were added. The 
reaction mixture was heated at 50-60°C for 3 h. After 
completion (monitored by TLC), the reaction was 
neutralized with HCl 1M; the reaction mixture was 
extracted with butanol. The organic phase was washed 
with water, dried over anhydrous Na2SO4, and concentrated 
under reduced pressure to afford the product. Cinnamic 
acid was obtained by recrystallization. Identification of 
cinnamic acid was performed by using FT-IR, LC-MS, 
1H-NMR, and 13C-NMR and GC-MS.
Cinnamic acid (2). Yield: (1.51 g, 85%). Mp: 133-
134°C. ESI-QToF MS m/z 149.09745 [M+H]+. FTIR: ν
max 
(cm-1), 3680 (C-OH), 1685 (C=O). 1H-NMR (500 MHz, 
CDCl3) δ 6.49 (d, 1H, J = 16 Hz), 7.83 (d, 1H, J = 16 Hz), 
7.57 (dd, 2H, J = 2.0, Hz; J = 7.8 Hz), 7.42 (dt, 3H, J = 
2.0, J =7.2 Hz), 13C-NMR (125 MHz, CDCl3) δ 172.8, 117.4, 
147.2, 134.1, 128.5, 129.1, 130.8, 129.1, 128.5. 
Amidation of cinnamic acid compound (series 3) 
In a 250 mL flask, SOCl2 (4 mL, 0.055 mol) was added 
dropwise to cinnamic acid (0.2961 g, 2 mmol) at 0°C and 
then heated for 5 h. The reaction mixture was cooled and 
anh. CH2Cl2 (10 mL), pyridine 0.2 mL, and (amine, 
ethylamine, propylamine, isopropylamine, octylamine, 
phenylamine, p-methoxyphenylamine) (6 mmol) were 
added and then stirred at room temperature for 3 h. The 
reaction mixture was washed with saturated NaCl and 
extracted with CH2Cl2. The organic layer was dried to give 
a crude product, which was purified by column 
chromatography (hex:AcOEt: 4:1) (Adisakwattana et al. 
2004; Carvalho et al. 2008).
Cinnamamide (3a)
Yield: (0.235 g, 80%). Mp: 145-148°C. ESI-QToF MS m/z 
148.07485 [M+H]+. FTIR: ν
max 
(cm-1), 3369 (NH), 1662 
(C=O). 1H-NMR (500 MHz, CDCl3) δ 6.43 (d, 1H, J = 16 
Hz), 7.64 (d, 1H, J = 16 Hz), 7.47 (dd, 2H, J = 9.75 Hz), 
7.35 (dt, 3H, J = 3.9 Hz, J = 9.75 Hz), 13C-NMR (125 MHz, 
CDCl3) δ 168.3, 119.2, 143.1, 134.5, 128.1, 128.9, 130.2, 
128.9, 128.1. 
Ethylcinnamamide (3b)
Yield: (0.262 g, 75%). Mp: 85-87°C. LCMS m/z 176.39 
[M+H]+, FTIR: ν
max 
(cm-1), 3284 (NH), 1656 (C=O). 
1H-NMR (500 MHz, CDCl3) δ 6.43 (d, 1H, J = 16 Hz), 7.64 
(d, 1H, J = 16 Hz), 7.47 (dd, 2H, J = 7.8 Hz), 7.35 (t, 3H, 
J = 1.95 Hz, J = 7.8 Hz), 3.42 (q, 2H, J = 2.6 Hz), 1.20 (t, 
1H, J = 7.15 Hz), 13C-NMR (125 MHz, CDCl3) δ 166.4, 
121.4, 140.5, 135.0, 127.8, 128.8, 129.6, 128.8, 127.8, 
34.7, 14.8. 
Propylcinnamamide (3c)
Yield: (0.31 g, 82%). Mp: 74-75°C. ESI-QToF MS m/z 
190.15952 [M+H]+. FTIR: ν
max 
(cm-1), 3269 (NH), 1654 
(C=O). 1H-NMR (500 MHz, CDCl3) δ 6.48 (d, 1H, J = 16 
Hz), 7.60 (d, 1H, J = 16 Hz), 7.45 (dd, 2H, J = 7.8 Hz), 
7.30 (dt, 3H, J = 3.25 Hz, J = 7.8 Hz), 3.34 (q, 2H, J = 
6.5 Hz), 1.58 (m, 2H, J = 7.15 Hz), 0.93 (t, 3H, J = 7.75 
Hz), 13C-NMR (125 MHz, CDCl3) δ 166.4, 121.2, 140.7, 
135.0, 127.8, 128.8, 129.6, 128.8, 127.8, 41.6, 22.9, 11.6. 
Isopropylcinnamamide (3d)
Yield: (0.295 g, 78%). Mp: 95-97°C. ESI-QToF MS m/z 
190.1568 [M+H]+. FTIR: ν
max 
(cm-1), 3265 (NH), 1656 
(C=O). 1H-NMR (500 MHz, CDCl3) δ 6.43 (d, 1H, J = 16 
Hz), 7.63 (d, 1H, J = 16 Hz), 7.47 (dd, 2H, J = 7.8 Hz), 
7.32 (t, 3H, J = 4.5 Hz, J = 7.8 Hz), 4.22 (m, 1H, J = 7.15 
Hz), 1.22 (d, 3H, J = 7.1 Hz), 1.22 (d, 3H, J = 7.1 Hz),13C-
NMR (125 MHz, CDCl3) δ 165.3, 121.2, 140.8, 134.9, 128.2, 
128.8, 129.6, 128.8, 128.2, 41.7, 22.9, 22.9. 
Octylcinnamamide (3e)
Yield: (0.477 g, 82.4%). Mp: 74-75°C. ESI-QToF MS m/z 
259.23412 [M+H]+. FTIR: ν
max 
(cm-1), 3282 (NH), 1631 
(C=O) 3059 and 2926 (CH aliphatic). 1H-NMR (500 MHz, 
CDCl3) 
317
δ 0.85 (t, J = 6.5 Hz, 3H), 1.56 (m, 2H, J = 7.8 Hz), 
1.24 (m, 2H, J = 3.9 Hz), 1.24 (m, 2H, J = 3.9 Hz), 1.24 
(m, 2H, J = 3.9 Hz), 1.24 (m, 2H, J = 3.9 Hz), 1.24 (m, 
2H, J = 3.9 Hz), 3.37 (q, 2H, J = 6.5 Hz), 7.48 (dd, 2H, J 
=7.8 Hz), 7.32 (dt, 3H, J =1.95 Hz, J =9.05 Hz), 7.64 (d, 
1H, J = 16 Hz), 6.46 (d, 1H, J = 16 Hz), 13C-NMR (125 
MHz, CDCl3) δ 14.2, 22.7, 31.8, 29.3, 29.4, 27.1, 29.7, 40.0, 
127.9, 128.9, 129.7, 128.9, 127.9, 134.9, 140.9, 120.8, 
166.2.
Phenylcinnamamide (3f)
Yield: (0.348 g, 78%). Mp: 77-79°C. ESI-QToF MS m/z 
224.10618 [M+H]+. FTIR: ν
max 
(cm-1), 3271 (NH), 1604 
(C=O). 1H-NMR (500 MHz, CDCl3) δ 6.69 (d, 1H, J = 16 
Hz), 7.16 (d, 1H, J = 16 Hz), 7.18 (dd, 2H, J = 7.15 Hz), 
6.78 (dt, 2H, J = 2.6 Hz, J = 8.4 Hz), 6.76 (dt, 1H, J = 2.6 
Hz, J = 8.4 Hz), 7.18 (dd, 2H, J = 8.4 Hz), 6.71 (dt, 2H, 
J = 2.6 Hz, J = 8.4 Hz), 6.69 (dt, 1H, J = 2.6 Hz, J = 8.4 
Hz), 13C-NMR (125 MHz, CDCl3) δ 164.7, 120.4, 142.4, 
134.9, 129.1, 128.9, 124.6, 128.9, 129.1, 138.2, 121.2, 
128.1, 130.0, 128.1, 121.2. 
p-Methoxyphenylcinnamamide (3g)
Yield: (0.394 g, 78%). Mp: 151-153°C. ESI-QToF MS m/z 
254.11655 [M]+. FTIR: ν
max 
(cm-1), 3250 (NH), 1610 (C=O). 
1H-NMR (500 MHz, CDCl3) δ 6.55 (d, 1H, J = 16 Hz), 7.75 
(d, 1H, J = 16 Hz), 7.54 (dd, 2H, J = 8.4 Hz), 7.37 (dt, 
3H, J = 2.6 Hz, J = 8.4 Hz), 7.52 (dd, 2H, J = 8.4 Hz), 
6.87 (dd, 2H, J = 8.4 Hz), 3.85 (s, 3H), 13C-NMR (125 MHz, 
CDCl3) δ 165.1, 120.9, 141.0, 139.1, 127.6, 128.7, 129.6, 
128.7, 127.6, 138.3, 121.5, 113.7, 156.7, 113.7, 121.5, 
55.01. 
Nitration of cinnamic acid (2c) and nitration of 
cinnamamide compound (series 4) 
Cinnamamide/cinnamic acid compound (4.05 mmol) was 
added to a mixture of H2SO4 (8.10 mmol) and HNO3 (8.10 
mmol). The mixture was stirred in an oil bath at 50°C, and 
the progress of the reaction was monitored by TLC. At the 
end of the reaction, the resulting mixture was diluted with 
ethyl acetate/water. The filtrate was washed with water (2 
× 10 mL) and dried with Na2SO4. The product was purified 
by column chromatography with the use of ethyl acetate-
hexane (2:1) as the eluent (Hurth et al. 2015; Lu et al. 2013; 
Montalbetti & Falque 2005; Oxley et al. 2008; Rodrigues 
et al. 1999). 
(E)3-(4-nitrophenyl)cinnamic acid (2c) 
Yield: (1.51 g, 45%). Mp: 147-148°C. ESI-QToF MS m/z 
193.04678 [M+H]+. FTIR: ν
max 
(cm-1), 3039 (NH), 1687 
(C=O), 1396 (NO). 1H-NMR (500 MHz, CDCl3 δ 6.55 (d, 
1H, J = 16 Hz), 7.75 (d, 1H, J = 16 Hz), 7.54 (d, 2H, J = 
8.4 Hz), 7.37 (d, 2H, J = 8.4 Hz), 13C-NMR (125 MHz, 
CDCl3) δ 172.8, 117.4, 147.2, 134.1, 128.5, 129.1, 130.8, 
129.1, 128.5. 
(E)3-(4-nitrophenyl)cinnamamide (4a)
Yield: (0.392 g, 50.4%). Mp: 147-148°C. ESI-QToF MS 
m/z 193.05678 [M+H]+. FTIR: ν
max 
(cm-1), 3039 (NH), 1687 
(C=O), 1396 (NO). 1H-NMR (500 MHz, CDCl3) δ 6.55 (d, 
1H, J = 16 Hz), 7.75 (d, 1H, J = 16 Hz), 7.54 (d, 2H, J = 
8.4 Hz), 7.37 (d, 2H, J = 8.4 Hz), 13C-NMR (125 MHz, 
CDCl3) δ 168.3, 119.2, 143.1, 134.5, 128.1, 128.9, 130.2, 
128.9, 128.1. 
(E)N-ethyl-(4-nitrophenyl)cinnamamide (4b)
Yield: (0.490 g, 55%). Mp: 138-139°C. ESI-QToF MS m/z 
221.10199 [M+H]+, FTIR: ν
max 
(cm-1), 3300 (NH), 1625 
(C=O), 1418 (NO), 1H-NMR (500 MHz, CDCl3) δ 6.55 (d, 
1H, J = 16 Hz), 7.75 (d, 1H, J = 16 Hz), 7.54 (d, 2H, J = 
8.4 Hz), 7.37 (d, 2H, J = 8.4 Hz), 3.42 (m, 2H, J = 2.6 
Hz), 1.20 (t, 1H, J = 7.15 Hz), 13C-NMR (125 MHz, CDCl3) 
δ 166.4, 121.3, 140.5, 135.0, 129.6, 128.8, 148.3, 129.6, 
128.8, 34.7, 14.9. 
(E)3-(4-nitrophenyl) N-propylcinnamamide (4c)
Yield: (0.62 g, 65.4%). Mp: 95-96°C. ESI-QToF MS m/z 
235.10663 [M+H]+. FTIR: ν
max 
(cm-1), 3275 (NH), 1631 
(C=O), 1336 (NO). 1H-NMR (500 MHz, CDCl3) δ 6.48 (d, 
1H, J = 16 Hz), 7.60 (d, 1H, J = 16 Hz), 7.45 (d, 2H, J = 
7.8 Hz), 7.30 (d, 2H, J = 7.8 Hz), 3.34 (q, 2H, J = 6.5 Hz), 
1.58 (m, 2H, J = 7.15 Hz), 0.93 (t, 3H, J = 7.75 Hz), 
13C-NMR (125 MHz, CDCl3) δ 165.2, 124.9, 135.9, 133.5, 
129.8, 129.2, 148.3, 129.2, 129.8, 41.7, 22.9, 11.5.
(E)3-(4-nitrophenyl) N-isopropylcinnamamide (4d)
Yield: (0.544 g, 57.4%). Mp: 154-155°C. ESI-QTOF MS 
m/z 235.10686 [M+H]+, FTIR: ν
max 
(cm-1), 3288 (NH), 1604 
(C=O), 1344 (NO). 1H-NMR (500 MHz, CDCl3) δ 6.46 (d, 
1H, J = 15.5 Hz), 7.67 (d, 1H, J = 15.5 Hz), 7.62 (d, 2H, 
J = 7.75 Hz), 8.23 (d, 2H, J = 7.75 Hz), 4.22(m, 1H, J 
=6.25 Hz), 1.23(d, 6H, J = 6.75 Hz), 13C-NMR (125 MHz, 
CDCl3) δ 165.3, 121.2, 140.8, 134.9, 128.2, 128.8, 129.6, 
128.8, 128.2, 41.7, 22.9, 22.9. 
(E)3-(4-nitrophenyl) N-octylcinnamamide (4e)
Yield: (0.6 g, 48.8%). Mp: 84-85°C. ESI-QToF MS m/z 
305.1897 [M+H]+. FTIR: ν
max 
(cm-1), 3300 (NH), 1625 
(C=O), 1336 (NO). 1H-NMR (500 MHz, CDCl3) δ 6.46 (d, 
1H, J = 16 Hz), 7.64 (d, 1H, J = 16 Hz), 7.48 (d, 2H, J 
=7.8 Hz), 7.32 (d, 2H, J =7.8 Hz), 3.37 (q, 2H, J = 6.5 
Hz), 1.24 (m, 10H, J = 7.8 Hz), 1.56 (m, 2H, J = 7.8 Hz), 
0.85 (t, 3H, J = 6.5 Hz), 13C-NMR (125 MHz, CDCl3) δ 
164.9, 124.9, 135.8, 133.4, 129.8, 129.2, 148.1, 129.2, 
129.8, 40.04, 31.9, 27.1, 29.3, 29.3, 29.7, 22.7, 14.2. 
Biological activity assays
Biological activity assays for the α-glucosidase enzyme 
inhibitory activity has been reported by Kim et al. (2004). 
S. cerevisiae α-glucosidase (0.5 mg) was dissolved in 5 
mL phosphate buffer at pH7, and 100 mg bovine was 
dissolved in 5 mL phosphate buffer. Both enzyme and 
bovine solutions were mixed into 40 mL phosphate buffer 
at pH7. Into a test tube was added a solution of 250 µL of 
20 mM p-NPG, 495 µL 100 mM phosphate buffer, and 5 
µL sample solution of each compound synthesized and 
incubated for 5 min at 37°C. Next, 250 µL of the enzyme 
was added and incubated for 15 min at 37°C. The reaction 
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was stopped by adding 1000 µL of Na2CO3 solution. 
Absorbance was then measured using a spectrophotometer 
at a wavelength of 400 nm. Percentage enzyme inhibition 
was measured as ((absorbance control-absorbance test)/
absorbance control) × 100.
Kim et al. (2004) was reported biological activity 
assays for the α-glucosidase enzyme which have been 
modified. Rat intestinal acetone powder α-glucosidase (500 
mg) was homogenized in 10 mL of 0.9% NaCl solution. 
After centrifugation (5000 rpm for 30 min), the solution 
was used in the experiment. Into a test tube was added a 
solution of 250 µL of 20 mM p-NPG, 595 µL 100 mM 
phosphate buffer, and 5 µL sample solution. After 
incubation for 5 min at 37°C, 150 µL of the enzyme was 
added and again incubated for 15 min at 37°C. The reaction 
was stopped by the addition of 1000 µL of Na2CO3 solution. 
Absorbance of the solution was then measured using a 
spectrophotometer at a wavelength of 400 nm. Percentage 
enzyme inhibition was measured as ((absorbance control-
absorbance test)/absorbance control) × 100. 
Measurement of kinetic constant
In order to investigate the type of inhibition, α-glucosidase 
enzyme kinetics analysis was performed according to a 
reported method (Adisakwattana et al. 2009). Kinetic 
analyses of the samples were performed using two reaction 
systems, i.e. the reaction system without the inhibitor and 
the reaction system with the sample inhibitor. The samples 
tested for their inhibitory kinetics were the best samples 
from previous inhibition test results (biological activity 
assay 2.2.4). The test was performed using different 
substrate concentrations (p-NPG), i.e. 0.5, 1, 3 5, 10 μM 
in phosphate buffer pH7. The reaction system mixture was 
similar to the mixture used for evaluating α-glucosidase 
inhibition. The absorbance was read at 400 nm, and the 
experiment was performed with 3 replicates. The type of 
inhibition was calculated on the basis of a Lineweaver-
Burk plot using reciprocally plotted data (substrate 
concentration on the horizontal axis and velocity on the 
vertical axis).
RESULTS AND DISCUSSION
SYNTHESIS OF CINNAMAMIDE DERIVATIVES
Synthetic cinnamamide derivatives were synthesized and 
assayed for their α-glucosidase inhibitory activities 
(Scheme 1 and Table 1). Basic hydrolysis of methyl trans- 
cinnamate 1 produced cinnamic acid 2. Treatment of 
cinnamic acid 2 with SOCl2 and alkylamine afforded the 
corresponding cinnamamide derivatives (3a-3g) in good 
yields. Thus obtained cinnamamide derivatives (3a-3g) 
were then nitrated with sulfuric acid and nitric acid, and 
nitro cinnamamide derivatives (4a-4e) were obtained in 
moderate yields. The structures of cinnamamide derivatives 
(3a-3g) and (4a-4e) were characterized by UV, IR, melting 
point analysis, 1H-NMR, 13C-NMR, GCMS, LCMS, and ESI-
QTOF mass spectral analysis. The UV absorption spectra 
O
R
R'
TABLE 1. Synthesis of cinnamamide derivatives
Entry Sample R R’ Melting point (°C) Yield (%)
1 Methyl cinnamate 1 OCH3 H 34-35 65
2 Cinnamic acid 2 OH H 133-134 85.5
3 Cinnamamide 3a NH2 H 145-148 80
4 Ethylcinnamamide 3b NHCH2CH3 H 85-87 75
5 Propylcinnamamide 3c NH CH2CH2CH3 H 74-75 82
6 Isopropylcinnamamide 3d NHCH(CH3)2 H 95-97 78
7 Octylcinnamamide 3e NH(CH2)7CH3 H 74-75 82.4
8 Phenylcinnamamide 3f NHC
6
H5 H 77-79 78
9 p-Methoxyphenylcinnamamide 3g NHC
6
H4OCH3 H 151-153 78
10 (E)3-(4-nitrophenyl)acrylic acid 2a OH NO2 165-168 56.4
11 (E)3-(4-nitrophenyl)acrylamide 4a NH2 NO2 147-148 50.4
12 (E)N-ethyl-(4-nitrophenyl) acrylamide 4b NHCH2CH3 NO2 138-139 55
13 (E)3-(4-nitrophenyl)propylacrylamide 4c NH CH2CH2CH3 NO2 95-96 65.4
14 (E)3-(4-nitrophenyl)N-isopropylacrylamide4d NHCH(CH3)2 NO2 154-155 57.4
15 (E)3-(4-nitrophenyl) N-octylacrylamide 4e NH(CH2)7CH3 NO2 84-85 48.8
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of 3a-3g and 4a-4e exhibited their main peak at 280 nm, 
upon introduction of the carbonyl and amide group, 
respectively. The IR spectrum of 3a-3g showed an 
absorption peak at 3250-3369 cm-1 due to the amine (-NH) 
stretching, and at 1662-1656 cm-1 due to the carbonyl amide 
(-N-C=O) stretching. The IR spectrum of 4a-4e showed an 
absorption peak at 3039-3300 cm-1 due to the amine (-NH) 
stretching, at 1604-1687 cm-1 due to carbonyl amide 
(-N-C=O) stretching, and at 1336-1418 cm-1 due to the 
nitro (-NO2) stretching. The 1H NMR spectrum of 3a-3g 
and 4a-4e showed a cinnamic acid backbone through 
doublet (d) at δ 6.43 ppm, doublet at δ 7.64 ppm, doublet-
doublet (dd) at δ 7.47 ppm, and  doublet-triplet (dt) at δ 
7.35 ppm, while an alkyl amine was evident by the 
following peak characteristics: ethylamide: triplets at δ 
1.20 ppm, quartet at δ 3.42 ppm; propylamide: quartet at 
δ 3.34 ppm, multiplets at δ 1.58 ppm, triplets at δ 0.93 
ppm; isopropylamide: multiplet at δ 4.22 ppm, doublets at 
δ 1.22 ppm; octylamide: quartet at δ 3.37 ppm, multiplets 
at δ 1.24 ppm,  multiplets at δ 1.56 ppm, and  triplets at δ 
0.85 ppm. The 13C NMR spectrum of 3a-3g and 4a-4e 
showed a cinnamic acid backbone through signals at δ 
119.2, 128.1, 128.9, 130.2, 130.5, 134.5, 143.1, and 168.3 
ppm, while an alkyl amine was evident by the following 
signals: ethylamide: 34.7 and 14.8 ppm; propylamide: 41.6, 
22.9, and 11.6 ppm; isopropylamide: 41.7 and 22.9 ppm; 
octylamide: 40.0, 31.8, 29.7, 29.4, 29.3, 27.1, 22.7, and 
14.2 ppm. Compounds 1, 2, 3a-3g, and 4a-4e were also 
identified by mass spectral analysis.
BIOLOGICAL ACTIVITY
α-Glucosidase inhibitory activity
Glucosidase is responsible for the catalytic disruption of 
glycosidic bonds, which depends explicitly on the amount 
of monosaccharides, the position of the cleavage site, and 
the configuration of the hydroxyl group in the substrate. 
Herein, we have synthesized 13 derivatives and report their 
inhibitory effects on α-glucosidase from S. cerevisiae and 
rat intestinal tissue. Ten compounds showed a more potent 
inhibition than standard acarbose, and five compounds 
showed a more potent inhibition than the standard 
1-deoxynojirimycin. However, all cinnamamide derivatives 
showed better inhibition of α-glucosidase than the starting 
material.
Thirteen compounds showed α-glucosidase activity 
with IC50 values of 0.71 ± 0.492–4.02 ± 0.025 mM 
(1-deoxynojirimycin: 0.97 ± 0.019 mM) and acarbose (IC50 
= 1.78 ± 0.727 mM). These compounds, based on the 
cinnamamide skeleton, only slightly differed from each 
other in their α-glucosidase inhibitory potential possible 
because of the different lengths of alkyl amine chain. 
Propylcinnamamide 3c (IC50 = 0.71 ± 0.492 mM), nitro 
propylcinnamamide 4c (IC50 = 0.75 ± 0.066 mM), 
FIGURE 1. IC50 values of cinnamamide derivatives for inhibition of α-glucosidase
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methoxyphenylcinnamamide 3g (IC50 = 0.80 ± 1.416), 
isopropylcinnamamide 3d (IC50 = 0.81 ± 0.757 mM), and 
nitro cinnamic acid 2a (IC50 = 0.95 ± 0.008 mM) showed 
the best activities, which were better than those of the 
standard 1-deoxynojirimycin and acarbose (Table 2).
In the assay for inhibitory potential against rat 
intestinal α-glucosidase, compounds 3c, 3g, 4b, 4d, and 
4e (IC50 = 0.37± 0.145 mM, 0.71 ± 0.160 mM, 0.66 ± 0.055 
mM, 0.59 ± 0.418 mM, and 0.59 ± 0.017 mM, respectively) 
had potent activities, which were equivalent to those of 
acarbose and 1-deoxynojirimycin (IC50 = 0.46 ± 0.251 mM 
and 0.20 ± 0.047 mM, respectively). Methyl trans-
cinnamate (1) and trans-cinnamic acid (2) were found to 
be inactive (IC50 > 20 mM). Propylcinnamamide (3c) had 
very potent inhibitory activity (IC50 = 0.37 ± 0.145 mM) 
and was the most active among all cinnamamide 
derivatives. These results suggested that presence of the 
amide group at the carboxyl group of cinnamic acid moiety 
is necessary to increase α-glucosidase inhibitory activity. 
Increasing the chain length of alkylamine increased 
α-glucosidase inhibitory activity up to an optimum chain 
length, any increase beyond this length decreased the 
inhibitory activity; Propylcinnamamide had an optimum 
chain length of alkyl amine, and therefore, had the best 
activity on intestinal α-glucosidase. Isopropylcinamamide 
showed lesser activity than propylcinnamamide because 
its alkyl amine was bulkier.
Figure 1 shows that methyl trans-cinnamate and trans-
cinnamic acid had a weak inhibitory activity against S. 
cerevisiae and rat intestinal α-glucosidase. Cinnamamide 
derivatives 3a-4e were more potent than methyl trans-
cinnamate and trans-cinnamic acid. Propylcinnamamide 
showed the best activity on intestinal α-glucosidase 
inhibition among the cinnamamide derivatives and was 
more potent than acarbose.
Inhibition kinetics of propylcinnamamide on α-glucosidase
The Lineweaver-Burk plot of α-glucosidase inhibition 
kinetics is shown in Figure 2 and shows that the 
m e c h a n i s m  o f  α - g l u c o s i d a s e  i n h i b i t i o n  o f 
propylcinnamamide (5) is competitive. The mechanism 
of inhibition of propylcinamide against the α-glucosidase 
enzyme in this study was studied through the Lineweaver-
Burk curve based on the reaction of enzymes with 
substrates and enzymes with substrates and inhibitors. 
Based on the results of the Lineweaver-burk plot, the 
O
R
R'
TABLE 2. IC50 values of cinnamamide derivatives for inhibition of α-glucosidase
Entry Sample R R’
IC50 ± SEM* (mM)
S. cerevisiae Rat intestinal
1 Methyl cinnamate 1 OCH3 H 1.88 ± 0.022 22.42 ± 0.011
2 Cinnamic acid 2 OH H 24.28 ± 0.019 25.37 ± 0.011
3 Cinnamamide 3a NH2 H 2.05 ± 0.020 1.86 ± 0.047
4 Ethylcinnamamide 3b NHCH2CH3 H 1.15 ± 1.006 2.52 ± 0.253
5 Propylcinnamamide 3c NH CH2CH2CH3 H 0.71 ± 0.492 0.37 ± 0.145
6 Isopropylcinnamamide 3d NHCH(CH3)2 H 0.81 ± 0.757 1.04 ± 0.054
7 Octylcinnamamide 3e NH(CH2)7CH3 H 1.59 ± 0.008 0.80 ± 0.092
8 Phenylcinnamamide 3f NHC
6
H5 H 4.02 ± 0.025 0.86 ± 0.184
9 p-Methoxyphenylcinnamamide 3g NHC
6
H4OCH3 H 0.80 ± 1.416 0.71 ± 0.160
10 (E)3-(4-nitrophenyl)acrylic acid 2a OH NO2 0.95 ± 0.008 0.99 ± 0.239
11 (E)3-(4-nitrophenyl)acrylamide 4a NH2 NO2 1.26 ± 0.047 0.96 ± 0.044
12 (E)N-ethyl-(4-nitrophenyl)acrylamide 4b NHCH2CH3 NO2 2.59 ± 0.052 0.66 ± 0.055
13 (E)3-(4-nitrophenyl) N-propylacrylamide 4c NH CH2CH2CH3 NO2 0.75 ± 0.066 0.98 ± 0.217
14 (E)3-(4-nitrophenyl)N-isopropylacrylamide 4d NHCH(CH3)2 NO2 1.21 ± 0.094 0.59 ± 0.418
15 (E)3-(4-nitrophenyl) N-octylacrylamide 4e NH(CH2)7CH3 NO2 1.73 ± 0.074 0.59 ± 0.017
16 1-Deoxynojirimycin 0.97 ± 0.019 0.20 ± 0.047
17 Acarbose 1.78 ± 0.727 0.46 ± 0.251
SEM, standard error of mean; 1-deoxynojirimycin and acarbose were used as standards
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propylsamamide compound works competitively (Figure 
2), when 1/[S] approaches 0, the maximum reaction speed 
(V max) is not affected by the presence of an inhibitor. 
Therefore, when the substrate concentration is high, V 
max in systems with inhibitors is equal to or close to V 
max with systems without inhibitors. Inhibitors that work 
competitively do not affect the value of Vmax, but 
increase the value of Km (Murray et al. 2003).
CONCLUSION
Thirteen compounds showed α-glucosidase activity (S. 
cerevisiae) with IC50 values of 0.71-4.02 mM. 
Propylcinnamamide (3c) (IC50 = 0.71 ± 0.492 mM), nitro 
propyl cinnamamide (4c) (IC50 = 0.75 ± 0.066), 
methoxyphenylcinnamamide (3g) (IC50 = 0.80 ± 1.416), 
isopropylcinnamamide (3d)) (IC50 = 0.81 ± 0.757), and 
nitro cinnamic acid (2a) (IC50 = 0.95 ± 0.008) showed the 
best activities, which were greater than those of the 
standards 1-deoxynojirimycin and acarbose. Compounds 
5, 9, 12, 14, and 15 (IC50 = 0.37 mM, 0.71 mM, 0.66 mM, 
0.59 mM, and 0.59 mM, respectively) showed potent 
α-glucosidase inhibitory activity (rat intestinal). The 
presence of amine substituents on cinnamic acid was 
responsible for the increase in the α-glucosidase inhibitory 
activity of the parent compound. An increase in the 
bulkiness and chain length of the amine substituents 
decreased the inhibitory activity. Propylcinnamamide (5) 
showed the highest inhibitory activity among all 
cinnamamide derivatives, and it acted via a competitive 
inhibitory mechanism. This study highlights compounds 
with the potential ability to regulate blood glucose levels 
and could be further developed for application in a clinical 
setting.
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